The global Albumin & Creatinine Tests market is anticipated to reach USD 990 million by 2021 and growing at a CAGR of 16.5% during the forecasting period, 2021-2028.
The growth of the global albumin & creatinine tests market is driven by the growing prevalence of kidney disorders/diseases, the rising adoption of POC diagnostics, and the increasing prevalence of chronic conditions. Kidney disease is one of the leading causes of death across the globe. Such cases—involving multiple kidney treatments—require the regular monitoring of components like creatinine and albumin and their ratios, for which multiple urine analysis products and techniques are used.
A challenge for this market is that most small hospitals and clinics with lower workloads still prefer semi-automated devices or manual analysis. Automated devices are primarily used by large hospitals with higher workloads; thus, the revenue generation can justify the costs incurred in installing automated analyzers.
Global Albumin & Creatinine Tests market is segmented into Product, Type, End-User,
Product segment is segmented into Analyzers, Cartridges (PoC, Tabletop), Dipsticks, Kits and Reagents
Type segment is segmented into Blood & Urine Creatinine, Urine Albumin, and Glycated Albumin
End-user segment is segmented into Hospital, Diagnostic & Research Labs
Geographically, the global Albumin & Creatinine Tests market is sub-segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions
Key players in the global Albumin & Creatinine Tests market are Roche Diagnostics, Abbott Laboratories, and Danaher Corporation.
The companies have come up with various promotional activities in the form of launch, investment, acquisition, and other, for instance:
|
Report Feature |
Descriptions |
|---|---|
|
Market Revenue In 2021 |
USD 990 Million |
|
Growth Rate |
CAGR of 16.5% during the forecasting period, 2021-2028 |
|
Historical Data |
2018-2019 |
|
Forecast Years |
2021-2028 |
|
Base Year |
2020 |
|
Units Considered |
Revenue in USD million and CAGR from 2021 to 2028 |
|
Report Segmentation |
Product, Type, End-user and |
|
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
|
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and the Middle East and Africa |
|
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe) |
|
Companies Profiled |
U.S., Roche Diagnostics, Abbott Laboratories, and Danaher Corporation |
|
Available Customization |
In addition to the market data for Albumin & Creatinine Tests market, Delvens. offers client-centric reports and customized according to the company’s specific demand and requirement. |
.png)
.png)
.png)
.png)
.png)
.png)